In a previous study, we found that healthy individuals had remarkably high levels of natural IgG antibodies against human vascular endothelial growth factor receptor 1 (VEGFR1) and that anti-VEGFR1 IgG-abundant plasma could inhibit the proliferation of liver cancer cells (Wang et al., 2017). This evidence concerns the gene FLT1 and liver cancer.